Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Experimental Medicine Année : 2021

Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A

Manju A Kurian

Résumé

Mitochondrial DNA (mtDNA) has been suggested to drive immune system activation, but the induction of interferon signaling by mtDNAhas not been demonstrated in a Mendelian mitochondrial disease. We initially ascertained two patients, one with a purely neurological phenotype, and one with features suggestive of systemic sclerosis in a syndromic context, and found them both to demonstrate enhanced interferon-stimulated gene (ISG) expression in blood. We determined each to harbor a previously described de novodominant-negative heterozygous mutation in ATAD3A, encoding ATPase family AAA domain-containing protein 3A(ATAD3A). We identified five further patients with mutations in ATAD3A, and recorded up-regulated ISG expression and interferon alpha protein in four of them. Knockdown of ATAD3Ain THP-1 cells resulted in increased interferon signaling, mediated by cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING). Enhanced interferon signaling was abrogated in THP-1 cellsand patient fibroblastsdepleted of mtDNA. Thus, mutations in the mitochondrial membrane protein ATAD3A define a novel type I interferonopathy.
Fichier principal
Vignette du fichier
20210714 Merged submitted JEM ATAD3A.pdf (14.03 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03736663 , version 1 (23-07-2021)
hal-03736663 , version 2 (12-04-2022)
hal-03736663 , version 3 (17-08-2023)
hal-03736663 , version 4 (07-09-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Alice Lepelley, Erika Della Mina, Erika van Nieuwenhove, Lise Waumans, Sylvie Fraitag, et al.. Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A. Journal of Experimental Medicine, 2021, 218 (10), pp.e20201560. ⟨10.1084/jem.20201560⟩. ⟨hal-03736663v2⟩
419 Consultations
115 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More